Researchers have identified SAILR, a long non-coding RNA, as a key regulator of macrophage survival. In the presence of pathogens, SAILR is rapidly silenced, leading to macrophage death and increased bacterial replication. This discovery could lead to new diagnostic markers and therapeutic targets for severe infections and inflammation.
Researchers have synthesized long noncoding RNA molecules with anti-inflammatory properties, demonstrating a new paradigm in drug discovery. The team identified three lncRNA sequences that regulate inflammation and used them to create nanoparticles that reduced inflammation in human cell cultures and mice.
Researchers studied MALAT1 levels in a woman with triple-negative breast cancer, finding high levels at diagnosis and decreased while receiving treatment. Notably, levels increased at a distant metastatic site, suggesting MALAT1's role in TNBC's spread. The study informs future treatments and potential clinical trials.
A team of researchers has identified a common sex-determining gene called ANTSR in both bees and ants, revealing a conserved mechanism that has been present for over 150 million years. This finding sheds light on the genetic basis of sex determination in these species and may have implications for bee conservation and breeding programs.
This study analyzed differential expression of long non-coding RNAs in peripheral blood mononuclear cells of women with luminal A breast cancer. Differential expression was observed, particularly for LINC RNA 974 (LINC00974), which exhibited significant associations with other oncological disorders.
A recent study reveals ADAMTS9-AS2/let-7a-5p axis inhibits the Warburg effect and OSCC progression, suggesting a promising therapeutic target for treatment. The study highlights the importance of metabolic reprogramming in OSCC.
Researchers have identified LINC01235 as a crucial regulator of NFIB expression and NOTCH pathway in TNBC, suggesting potential therapeutic targets for this aggressive form of breast cancer. The study provides new insights into the role of non-coding RNAs in cancer progression.
A Chinese Medical Journal study investigates the role of non-coding RNAs in pancreatic cancer, revealing how dysregulation of these molecules contributes to tumor growth and treatment resistance. The research highlights potential therapeutic targets for this devastating disease.
A research team has identified a long noncoding RNA named ESSENCE as a critical regulator of tumor progression in colorectal cancer. ESSENCE stabilizes a key metabolic enzyme, CAD, to promote cancer growth and suppress ferroptosis. This discovery proposes a novel combination therapy targeting ESSENCE-high tumors.
Long non-coding RNAs (lncRNAs) play a crucial role in regulating the tumor microenvironment, influencing processes such as immune evasion, angiogenesis, and metastasis. They mediate interactions between tumor cells and their surrounding microenvironment, modulating stromal cell activities and promoting tumor growth and survival.
Long non-coding RNAs (lncRNAs) play a critical role in metabolic and fibrotic pathways, influencing lipid metabolism, inflammation, apoptosis, and fibrogenesis. Targeting pathogenic lncRNAs or enhancing protective ones may provide a dual approach for MASLD treatment.
A UC Riverside-led team, funded by the NIH, aims to uncover molecular factors governing gene regulation and chromatin organization in P. falciparum. The project focuses on long non-coding RNAs, which play a crucial role in regulating gene expression and influencing disease progression.
A new study uses CRISPR-Cas13 to identify nearly 800 noncoding RNAs that are functional and essential for cell function, including in cancer and human development. The researchers found that these RNA molecules modulate key pathways for cell proliferation and can serve as potential biomarkers and therapeutic targets for cancer treatment.
Researchers identified three long noncoding RNAs associated with worse outcomes in colorectal cancer patients, potentially serving as prognostic markers. The study's findings could enable doctors to separate high-risk patients from those at low risk of disease recurrence, leading to more effective treatment strategies.
Scientists have discovered a long non-coding RNA called CHASERR that regulates the production of the CHD2 gene, which is associated with neurodevelopmental disorders. The study found that patients with a deletion of this RNA had excessive CHD2 protein production, leading to severe intellectual delays and other symptoms.
Researchers from Japan have discovered that Exportin-5 interacts with a broader spectrum of RNAs, including tRNAs, miRNAs, lncRNAs, and specific mRNAs. This study sheds light on the unique roles of Exp5 in RNA export within Drosophila cells.
A team of international researchers has discovered a surprising genetic mechanism that influences the vibrant patterns on butterfly wings. An RNA molecule controls where dark pigments are made during butterfly metamorphosis, shaping the butterfly's color patterns in a way previously unforeseen.
Researchers at U of T mapped the spatial distribution of long non-coding RNAs in testes, finding higher levels than previously estimated. The study suggests lncRNAs play a more significant role in male reproduction and may influence sperm development and behavior.
The study reveals that non-coding RNAs, including microRNAs, long non-coding RNAs, and circular RNAs, play a crucial role in regulating the Notch signaling pathway in breast cancer. These molecules can modulate gene expression and affect cancer cell proliferation, invasion, and metastasis.
A team of UC Santa Cruz researchers has identified a peptide in human RNA that plays a crucial role in regulating inflammation. The discovery provides a promising target for developing new treatments for inflammatory diseases such as arthritis and lupus.
Long non-coding RNAs (lncRNAs) play crucial roles in regulating protein-coding gene expression and respond to environmental stresses in fruits and vegetables. Recent research reveals the formation, functional characteristics, and regulatory mechanisms of lncRNAs in these crops.
A new computational pipeline, Plant-LncPipe, significantly improves plant lncRNA identification by retraining mainstream models on high-quality plant data. The study demonstrates that species-specific retraining enhances prediction precision and reliability.
Researchers found a shared triple network of long noncoding RNAs, microRNAs, and messenger RNAs that exacerbates Parkinson's disease symptoms in the context of COVID-19 infection. The study identified key genes and lncRNAs as potential biomarkers for PD diagnosis and progression.
A team of researchers has identified two long noncoding RNA genes that control multiple traits in wild soybeans, including insect resistance and leaf growth. These findings can aid in the development of new domesticated soybean varieties with improved seed composition and nutritional traits.
Researchers identified elevated MALAT1 levels in various blood cancers, correlating with adverse outcomes. MALAT1 promotes cancer cell proliferation, migration, invasion, and metastasis through multiple mechanisms.
Researchers at CRAG have made groundbreaking discoveries on seed germination, identifying key regulatory features and non-coding RNAs that drive the process. The study reveals that transcription restarts much earlier than previously thought, opening up new avenues for investigation into the role of the non-coding genome.
A long non-coding RNA called lncREST has been identified as a crucial component of the stress response during DNA replication. Its absence leads to impaired stress signalling, resulting in severe DNA defects and cell death. The discovery opens up new avenues for developing anti-tumour therapies.
A new study found that MERRICAL, a long non-coding RNA sequence, is involved in recruiting macrophages to the arterial wall and promotes atherosclerosis progression. Reducing MERRICAL expression levels using inhibitors significantly reduced atherosclerosis and aortic lesion formation.
A study published in Seed Biology has identified 20,893 lncRNAs associated with wheat grain development, revealing their role in regulating seed germination and end-use quality. The comprehensive atlas provides insights into the functions of lncRNAs, laying groundwork for future research on boosting wheat yields and quality.
Scientists have identified a long non-coding RNA called SNHG8 that plays a crucial role in the development of toxic protein tangles in brain diseases like Alzheimer's. Replacing this RNA can prevent stress granule formation, which contributes to tau aggregation and brain damage.
Researchers detected distinct RNA patterns in healthy and preeclampsia-affected pregnancies, identifying messenger RNA, microRNA, and long noncoding RNA as potential biomarkers. The study developed classifiers for predicting preterm and early-onset preeclampsia with high accuracy.
A study by Professor Tongming Yin's team reveals the proposed role of MSL-lncRNAs in causing sex lability of female poplars. The researchers detected multiple cis-activating elements in the MSL gene, which generated long non-coding RNAs promoting maleness and leading to female lability.
Researchers found that MALAT1 inhibition decreased BRAF RNA and protein levels, while increasing correlation with MAPK-associated genes. MALAT1-ASO treatment also reduced melanoma cell growth and tumor size in xenograft models.
Researchers have identified distinct senescence subpopulations and dynamic changes in the transcriptome of human cells undergoing senescence. The study provides new understanding of the heterogeneous nature of senescence and its impact on aging diseases.
CARMN is a long noncoding RNA that regulates contractility in both blood vessels and the gastrointestinal tract. Without CARMN, mice cannot survive due to impaired GI tract contraction, leading to conditions like intestinal pseudo-obstruction.
Researchers found that lncRNA MVIH is overexpressed in cervical cancer tumors and associated with younger age, lymph node metastasis, tumor invasion depth, and squamous cell type. This suggests its potential as a diagnostic biomarker for cervical cancer.
Researchers at the University of Bern identified new targets for drug development in non-small cell lung cancer, a largely incurable type of cancer. The study focused on long noncoding RNAs, which were found to play a crucial role in NSCLC cell division and tumor growth.
A new biomarker called SPRIGHTLY could distinguish between two aggressive types of brain tumors in children: Group 3 and Group 4 medulloblastomas. The biomarker is highly expressed in Group 4 medulloblastomas, which have a poorer prognosis.
Researchers have identified a group of deregulated genes in pancreatic cancer that may serve as potential therapeutic targets. These long non-coding RNAs, when silenced, reduced tumor aggressiveness and characteristics such as proliferation and invasion.
Researchers from the University of Bath have made significant breakthroughs in understanding how a type of gene regulates essential nerve cells. Long non-coding RNAs (lncRNAs) play a crucial role in controlling brain development and function, particularly during embryonic development and early life.
Researchers uncover the pleiotropic functions of hnRNPK in regulating skeletal muscle cell differentiation, including inhibition of myoblast differentiation and suppression of genes involved in endoplasmic reticulum stress. The study suggests that targeting hnRNPK could be a potential therapeutic strategy for treating human disorders.
The study of MUNC long non-coding RNA reveals the importance of experimentally determining its structure to identify functional domains. The researchers found that two structural domains, including six common 'hairpins,' were crucial for regulating gene expression and muscle cell differentiation.
A comprehensive review highlights recently discovered associations between lncRNAs and specific diseases, including fatty liver disease and liver cancer. The study suggests that a diverse group of molecules known as long noncoding RNAs could emerge as biomarkers for liver disease.
Researchers found that knocking down LCDR in lung cancer cells promotes apoptosis, providing a potential new target for diagnosis and treatment. Additionally, targeting LCDR shows promise as a therapeutic strategy and has diagnostic value for lung adenocarcinoma.
Scientists have discovered a new layer of regulation in plant-microbe interactions using peanut studies. An antisense long-noncoding RNA, DONE40, was found to bind to a protein involved in epigenetic control, suggesting a conserved function across plants and animals.
Researchers at Karolinska Institutet have identified a specific connection between a protein and an lncRNA molecule that can help decrease fat depots in tumor cells, leading to cell division cessation and cancer cell death. The study contributes to increased knowledge of liver cancer diagnosis and future treatments.
The study found that exercise induces expression of long noncoding RNA CYTOR, which enhances myogenic differentiation and improves muscle morphology and function in aged muscles. CYTOR also re-configures chromatin accessibility at binding sites of other genes, shedding light on its mechanisms.
Researchers identified 166 prognostic biomarkers from long non-coding RNAs, with one biomarker, HOXA10-AS, showing high effectiveness in categorizing gliomas as low- or high-risk. The study provides potential therapeutic targets and insights into cancer biology.
Researchers identified LAPAS1 as a novel E2F-regulated lncRNA that plays a role in human cancer and regulates cell-cycle progression and cell proliferation. Inhibition of LAPAS1 expression delays cell progression through S phase and inhibits proliferation of human cancer cells.
Researchers identify 'antisense long non-coding RNA' regulating tau protein production, a crucial mechanism for brain cell function. The discovery may lead to new treatments for dementia-related diseases, including Parkinson's and Alzheimer's.
Understanding how tau protein is regulated in brain cells could lead to better treatments for Parkinson's and other neurological conditions. Researchers discovered that similar lncRNAs control the production of tau and other key proteins involved in brain function.
Researchers at Michigan Medicine identified a long noncoding RNA, LIMIT, that promotes the body's immune response against cancer. By activating key genes and pathways, LIMIT boosts T cell infiltration into tumors, offering new potential therapeutic approaches to overcome immune evasion in human cancers.
Researchers found four lncRNAs linked to cytokine storms in severe SARS-CoV-2 infection, suggesting potential therapeutic targets. The study sheds light on immune dysfunction mechanisms and informs novel approaches for treating severe COVID-19 patients.
A new study reveals that the long noncoding RNA ADEPTR is essential for structural plasticity in neurons, forming and amassing at the synapse upon stimulation. Silencing ADEPTR prevents new synapses from forming during stimulation, highlighting its crucial role in neural adaptation.
A new study reveals that a long noncoding RNA molecule named Linc00402 plays a key role in mobilizing the immune response after bone marrow or solid organ transplantation. The researchers found that inhibiting this RNA could improve outcomes for transplant recipients, reducing the risk of graft-versus-host disease and cancer relapse.
Researchers identified GAPLINC, a long noncoding RNA that regulates inflammatory gene expression and protects mice from septic shock. The study found that reducing GAPLINC levels enhanced inflammatory responses, but unexpectedly, this effect also protected mice from endotoxic shock.
Researchers identified MAARS, a lncRNA expressed specifically in macrophages of atherosclerotic plaques, contributing to disease progression. Targeted interruption of MAARS's function reduced atherosclerotic lesion formation by 52%.
Scientists at Duke-NUS Medical School have discovered that long non-coding RNAs (lncRNAs) play a key role in pancreatic cancer development by modifying cell growth. The study highlights the importance of investigating lncRNAs in living organisms and provides potential new targets for precision cancer therapies.
Researchers at Moffitt Cancer Center discovered specific molecules, TAp63, long noncoding RNA (lncRNA), and proteins WDR26 and NOLC1 that regulate AKT signaling pathway to promote tumor development and progression.
Two studies published in Genome Research provide new insights into the core regulatory networks governing cell types across different vertebrate species. The research highlights the importance of understanding RNA expression in establishing cell function, morphology, and behavior. Long non-coding RNAs were found to affect cell growth a...